Pharma News Intelligence January 5, 2024
Veronica Salib

Eli Lilly and Company is launching LillyDirect, a digital healthcare platform used to manage obesity, migraine, and diabetes for patients in the US.

Yesterday, January 4, 2024, Eli Lilly and Company issued a press release announcing the launch of LillyDirect. The platform is a digital healthcare tool for managing and supporting patients with obesity, migraine, and diabetes in the United States.

According to the release, LillyDirect offers multiple services for disease management, support, and medication delivery.

The press release highlights multiple features but primarily focuses on the LillyDirect Pharmacy Solutions feature. Through LillyDirect Pharmacy Solutions, the company’s platform connects users to a third-party online pharmacy fulfillment service. The thought behind this aspect is to make it easier for patients to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Telehealth
Four AI Disruptions in 2025 That Will Reshape Pharma and Healthcare
Amazon's RxPass Shown to Improve Days' Supply, Refills, and Out-of-Pocket Costs for Common Medications
Wegovy and Ozempic stars dim amid overuse concerns
LinkedIn Founder Reid Hoffman’s New AI Startup May Revolutionize Cancer Care
5 Key AI Players Leading the Drug Discovery Push

Share This Article